How many insider trades does FilingIQ track for KLTO?

FilingIQ tracks 17 Form 4 insider transactions for KLTO (Klotho Neurosciences, Inc.), covering filings from Jul 22, 2025 onwards. 6 of those were filed in the last 90 days.

Are KLTO insiders net buyers or net sellers?

Across the full Form 4 history for KLTO, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does KLTO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is KLTO in?

Klotho Neurosciences, Inc. (KLTO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.27M.

KLTO insider trading

NasdaqCM Healthcare

Klotho Neurosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$33.27M

About Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Company website: klothoneuro.com

KLTO insider activity at a glance

FilingIQ has scored 17 insider transactions for KLTO since Jul 22, 2025. The most recent filing in our index is dated Mar 4, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live KLTO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for KLTO?: FilingIQ tracks 17 Form 4 insider transactions for KLTO (Klotho Neurosciences, Inc.), covering filings from Jul 22, 2025 onwards. 6 of those were filed in the last 90 days.
Are KLTO insiders net buyers or net sellers?: Across the full Form 4 history for KLTO, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does KLTO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is KLTO in?: Klotho Neurosciences, Inc. (KLTO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.27M.

Methodology & sources

Every KLTO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.